FR2275217A1 - Compositions aqueuses de rafoxanide utiles comme medicaments - Google Patents

Compositions aqueuses de rafoxanide utiles comme medicaments

Info

Publication number
FR2275217A1
FR2275217A1 FR7518864A FR7518864A FR2275217A1 FR 2275217 A1 FR2275217 A1 FR 2275217A1 FR 7518864 A FR7518864 A FR 7518864A FR 7518864 A FR7518864 A FR 7518864A FR 2275217 A1 FR2275217 A1 FR 2275217A1
Authority
FR
France
Prior art keywords
rafoxanide
compositions
aqueous
medicinal products
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7518864A
Other languages
English (en)
French (fr)
Other versions
FR2275217B1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2275217A1 publication Critical patent/FR2275217A1/fr
Application granted granted Critical
Publication of FR2275217B1 publication Critical patent/FR2275217B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7518864A 1974-06-19 1975-06-17 Compositions aqueuses de rafoxanide utiles comme medicaments Granted FR2275217A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48064574A 1974-06-19 1974-06-19

Publications (2)

Publication Number Publication Date
FR2275217A1 true FR2275217A1 (fr) 1976-01-16
FR2275217B1 FR2275217B1 (ja) 1979-08-17

Family

ID=23908782

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7518864A Granted FR2275217A1 (fr) 1974-06-19 1975-06-17 Compositions aqueuses de rafoxanide utiles comme medicaments

Country Status (10)

Country Link
JP (1) JPS5821888B2 (ja)
BE (1) BE830383A (ja)
CA (1) CA1042797A (ja)
DE (1) DE2526986A1 (ja)
FR (1) FR2275217A1 (ja)
GB (1) GB1472385A (ja)
IL (1) IL47448A (ja)
NL (1) NL184257C (ja)
PH (1) PH12304A (ja)
ZA (1) ZA753921B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003682A1 (en) * 1978-02-13 1979-08-22 Merck & Co. Inc. Process for solubilizing an insoluble drug and an aqueous solution prepared by this process
FR2577437A1 (fr) * 1985-02-21 1986-08-22 Corbiere Jerome Nouveau procede de solubilisation des composes chimiques et les preparations aqueuses ainsi obtenues
EP1129713A1 (en) * 2000-02-29 2001-09-05 New Pharma Research Sweden AB Veterinary compositions for the treatment of parasitic diseases

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2247884B (en) * 1990-09-11 1994-05-11 Chanelle Chemicals Ltd Manufacture of a salicylanilide derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD92776A (ja) *
DE1089510B (de) * 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
DE1209700B (de) * 1964-05-02 1966-01-27 Boehringer & Soehne Gmbh Verfahren zur Herstellung einer wasserloeslichen Zubereitungsform des 3, 5-Dinitro-o-toluamids
NL6816239A (ja) * 1967-12-01 1969-06-03

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003682A1 (en) * 1978-02-13 1979-08-22 Merck & Co. Inc. Process for solubilizing an insoluble drug and an aqueous solution prepared by this process
FR2577437A1 (fr) * 1985-02-21 1986-08-22 Corbiere Jerome Nouveau procede de solubilisation des composes chimiques et les preparations aqueuses ainsi obtenues
EP1129713A1 (en) * 2000-02-29 2001-09-05 New Pharma Research Sweden AB Veterinary compositions for the treatment of parasitic diseases
WO2001064222A1 (en) * 2000-02-29 2001-09-07 New Pharma Research Sweden Ab Veterinary compositions for the treatment of parasitic diseases
US6777448B2 (en) 2000-02-29 2004-08-17 New Pharma Research Sweden Ab Veterinary compositions for the treatment of parasitic diseases

Also Published As

Publication number Publication date
FR2275217B1 (ja) 1979-08-17
NL7506618A (nl) 1975-12-23
GB1472385A (en) 1977-05-04
JPS5821888B2 (ja) 1983-05-04
BE830383A (fr) 1975-12-18
PH12304A (en) 1979-01-16
NL184257B (nl) 1989-01-02
DE2526986C2 (ja) 1987-11-05
ZA753921B (en) 1977-01-26
AU8197375A (en) 1976-12-16
CA1042797A (en) 1978-11-21
IL47448A (en) 1978-04-30
NL184257C (nl) 1989-06-01
IL47448A0 (en) 1975-08-31
DE2526986A1 (de) 1976-01-08
JPS5126212A (ja) 1976-03-04

Similar Documents

Publication Publication Date Title
BE824359A (fr) Derives biphenyles utiles comme medicaments
ZA751806B (en) Pharmaceutical compositions
IL48642A (en) 3-amino-indazolecarboxylic acid derivatives,ther preparation and pharmaceutical compositions containing them
BE826923A (fr) (polyacoxy-phenyl)-4-pyrrolidinones-2 medicaments qui en contiennent
ZA74385B (en) Pharmaceutical compositions
ZA755998B (en) Pharmaceutical compositions
FR2352808A1 (fr) Acides 12-azaprostanoiques utiles comme medicaments
BE865624A (fr) Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
IL47412A0 (en) Prostaglandin conjugates,their preparation and pharmaceutical compositions containing them
IL48508A (en) Pharmaceutical compositions comprising piperidylindole derivatives
AU487061B2 (en) Pharmaceutical compositions
BE825135A (fr) Derives de la benzofurannone utilisables comme medicaments
FR2275217A1 (fr) Compositions aqueuses de rafoxanide utiles comme medicaments
BE803803A (fr) Nouvelles piperazino-pyrimidines utilisables comme medicaments
BE832277R (fr) Nouvelles piperazilo-pyrimidines utilisables comme medicaments
HK17281A (en) Pharmaceutical compositions
IL47299A (en) 3-thiomethyl-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
FR2332017A1 (fr) Antibiotiques de type thienamycine utiles comme medicaments
BE816445A (fr) Derives bis-amines utiles comme medicaments
FR2315259A1 (fr) Nouvelles amidines terpenoaromatiques utilisables comme medicaments
ZA755802B (en) Pharmaceutical compositions
IL48230A0 (en) Pharmaceutical compositions containing 2-naphthyl-butyric acid derivatives
PH12855A (en) Pharmaceutical compositions
MY7900033A (en) Pharmaceutical compositions
FR2326187A1 (fr) Acyl cyanoguanidines utilisables comme medicaments